GPR124 Antikörper (PE-Cy5.5)
Kurzübersicht für GPR124 Antikörper (PE-Cy5.5) (ABIN1713170)
Target
Alle GPR124 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Maus, Ratte (Rattus), Hund, Schwein, Rind (Kuh)
-
Aufreinigung
- purified by Protein A
-
Immunogen
- KLH conjugated synthetic peptide derived from human G protein coupled receptor 124
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
FCM(1:100-500)
Optimal working dilution should be determined by the investigator. -
Kommentare
-
Excitation / Emission wavelength: 496,565nm / 690nm
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 µg/µL
-
Buffer
- Aqueous buffered solution containing 100 µg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 4 °C for 12 months
-
Haltbarkeit
- 12 months
-
-
- GPR124 (G Protein-Coupled Receptor 124 (GPR124))
-
Andere Bezeichnung
- GPR124
-
Hintergrund
- Tumor endothelial markers (TEMs) are abundantly expressed in the blood vessels of human solid tumors during angiogenesis and neoangiogensis. These include TEM1 (endosialin), TEM5 (G-protein coupled receptor 124) and TEM7 (plexin domain containing 1). TEMs are associated with the cell surface membrane at low levels in normal human and mouse tissues. TEM5 is a seven-pass transmembrane receptor, whereas TEM1, TEM7 and TEM8 span the membrane once. TEM5 expression is elevated during tumor angiogenesis and neoangiogenesis. TEM7 is highly expressed in tumor endothelium and neurons. Therefore, TEM5 and TEM7 may be suitable targets for the development of antiangiogenic therapies.
-
Gen-ID
- 25960
Target
-